4.7 Review

Moyamoya disease: diagnosis and interventions

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Revascularization of Hemorrhagic Moyamoya Disease in a North American Cohort: The Role of Timing in Perioperative and Long-Term Outcomes

Risheng Xu et al.

Summary: This study compared the clinical outcomes of conservative management and surgical revascularization for North American patients with hemorrhagic MMD. The results showed that conservative management was associated with higher mortality and worsened neurological outcomes, while early revascularization was associated with higher rates of postoperative seizures and wound complications.

NEUROSURGERY (2022)

Article Clinical Neurology

Asymptomatic Moyamoya Disease in a North American Adult Cohort

Pui Man Rosalind Lai et al.

Summary: This study investigated the natural history of asymptomatic adult moyamoya disease (MMD) in a North American cohort and evaluated the effects of treatment on disease progression. The results showed an overall 1.7% annual rate of radiographic infarction or hemorrhage in asymptomatic MMD patients. Surgical treatment did not show significant benefits within the study period, but asymptomatic patients with expected long-term survival may benefit from surgery.

WORLD NEUROSURGERY (2022)

Article Biology

MMD-associated RNF213 SNPs encode dominant-negative alleles that globally impair ubiquitylation

Abhishek Bhardwaj et al.

Summary: Single-nucleotide polymorphisms in the RNF213 gene are associated with moyamoya disease (MMD), a rare cerebrovascular disorder. These SNPs primarily affect the E3 ligase activity of RNF213, and the pathogenesis of MMD is closely linked to the decreased E3 ligase activity of RNF213.

LIFE SCIENCE ALLIANCE (2022)

Article Clinical Neurology

Five-Year Outcomes of Medical Management Alone for Adult Patients with Ischemic Moyamoya Disease without Cerebral Misery Perfusion

Kei Kitakami et al.

Summary: The study followed 68 adult patients with ischemic MMD without cerebral misery perfusion for 5 years, revealing a 3% rate of further ischemic events during the subsequent 3-year follow-up. In patients without additional events, cerebral blood flow significantly increased and cognitive function remained stable or improved over the 5-year period.

CEREBROVASCULAR DISEASES (2022)

Article Cardiac & Cardiovascular Systems

Association of Antiplatelet Therapy, Including Cilostazol, With Improved Survival in Patients With Moyamoya Disease in a Nationwide Study

Woo-Keun Seo et al.

Summary: Administration of antiplatelet agents can reduce the risk of death in patients with moyamoya disease, with cilostazol showing greater survival benefit compared to other antiplatelet regimens. Various analyses consistently supported the use of antiplatelet therapy in patients with moyamoya disease.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Article Multidisciplinary Sciences

Ring finger protein 213 assembles into a sensor for ISGylated proteins with antimicrobial activity

Fabien Thery et al.

Summary: The researchers identify RNF213 as a sensor for ISGylated proteins on the surface of lipid droplets, showing both antiviral properties and the ability to target intracellular bacteria. RNF213, induced by interferon, exhibits broad antimicrobial activity against various infections and oligomerizes on lipid droplets as a sensor for ISGylated proteins.

NATURE COMMUNICATIONS (2021)

Article Genetics & Heredity

A new syndrome of moyamoya disease, kidney dysplasia, aminotransferase elevation, and skin disease associated with de novo variants in RNF213

Alanna Strong et al.

Summary: RNF213 protein may cause Mendelian moyamoya disease and act as a genetic susceptibility locus, leading to a new multi-organ spectrum disease.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2021)

Article Cell Biology

Dysregulation of Rnf 213 gene contributes to T cell response via antigen uptake, processing, and presentation

Ryosuke Tashiro et al.

Summary: The study found that RNF213 plays a critical role in antigen uptake, processing, and presentation, with Rnf213-KO and Rnf213-KI mice experiments showing that RNF213 deficiency leads to decreased antigen uptake and processing capabilities, resulting in the inability to effectively activate antigen-specific T cells.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Article Multidisciplinary Sciences

Ubiquitylation of lipopolysaccharide by RNF213 during bacterial infection

Elsje G. Otten et al.

Summary: The study reveals that the ubiquitin coat on Salmonella invading the cytosol is formed through the ubiquitylation of the lipid A moiety of bacterial lipopolysaccharide by E3 ubiquitin ligase RNF213, which is a risk factor for moyamoya disease. RNF213 is essential for restricting bacterial proliferation and triggering the generation of the bacterial ubiquitin coat, leading to cell-autonomous immunity against intracellular bacteria.

NATURE (2021)

Article Clinical Neurology

Direct vs Indirect Revascularization in a North American Cohort of Moyamoya Disease

Pui Man Rosalind Lai et al.

Summary: This study found no significant difference in outcomes between direct and indirect revascularization procedures in adults with ischemic MMD. There were fewer long-term ischemic and hemorrhagic events in hemispheres with direct bypasses compared to indirect bypasses. However, both procedures showed similar outcomes in terms of infarction and hemorrhage, as well as clinical outcome.

NEUROSURGERY (2021)

Article Peripheral Vascular Disease

The association between the Moyamoya disease susceptible gene RNF213 variant and incident cardiovascular disease in a general population: the Nagahama study

Yasuharu Tabara et al.

Summary: The study indicates an association between the Moyamoya disease susceptible gene RNF213 variant and the incidence of cardiovascular disease in the Japanese general population. Carriers of the variant allele had a higher incidence rate of cardiovascular diseases, particularly major adverse cardiac events.

JOURNAL OF HYPERTENSION (2021)

Article Clinical Neurology

Transcriptome-wide analysis of intracranial artery in patients with moyamoya disease showing upregulation of immune response, and downregulation of oxidative phosphorylation and DNA repair

Fumiaki Kanamori et al.

Summary: This study identified a specific gene expression profile within the intracranial artery of patients with MMD, showing upregulation of genes related to immune responses and downregulation of genes related to DNA repair and oxidative phosphorylation. These findings provide insights into the pathophysiology of MMD.

NEUROSURGICAL FOCUS (2021)

Article Clinical Neurology

DIAPH1 Variants in Non-East Asian Patients With Sporadic Moyamoya Disease

Adam J. Kundishora et al.

Summary: A genetic association study identified rare damaging variants associated with Moyamoya disease (MMD) risk, suggesting DIAPH1 as a novel MMD risk gene and highlighting the importance of impaired vascular cell actin remodeling in MMD pathogenesis for diagnostic and therapeutic implications.

JAMA NEUROLOGY (2021)

Article Behavioral Sciences

A meta-analysis of comparisons of various surgical treatments for moyamoya diseases

Kai Lin et al.

Summary: This study revealed that direct and combined bypass surgeries have a lower recurrence rate of stroke compared to indirect bypass surgery in treating MMD. Additionally, cases undergoing direct bypass surgery showed better angiographic changes than those undergoing an indirect bypass.

BRAIN AND BEHAVIOR (2021)

Review Medicine, General & Internal

Differences in Clinical Features among Different Onset Patterns in Moyamoya Disease

Yudai Hirano et al.

Summary: Moyamoya disease is characterized by severe stenosis of the bilateral internal carotid arteries and the development of collateral circulation, with diverse age at onset, onset patterns, radiological findings, and genetic phenotypes. Screening with magnetic resonance imaging has increased the identification of asymptomatic cases, and recent reports have investigated the associations between clinical features and imaging characteristics of different onset patterns.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Clinical Neurology

Arterial wall contrast enhancement in progressive moyamoya disease

Constantin Roder et al.

JOURNAL OF NEUROSURGERY (2020)

Review Clinical Neurology

Moyamoya Disease and Spectrums of RNF213 Vasculopathy

Oh Young Bang et al.

TRANSLATIONAL STROKE RESEARCH (2020)

Article Biochemistry & Molecular Biology

Vascular Remodeling in Moyamoya Angiopathy: From Peripheral Blood Mononuclear Cells to Endothelial Cells

Francesca Tinelli et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Clinical Neurology

Characteristics of cognitive impairment in adult asymptomatic moyamoya disease

Shihao He et al.

BMC NEUROLOGY (2020)

Article Cardiac & Cardiovascular Systems

Prospective Screening of Extracranial Systemic Arteriopathy in Young Adults with Moyamoya Disease

Tae Keun Jee et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)

Editorial Material Psychiatry

Psychiatric Comorbidity in Moyamoya Disease and Preliminary Guidelines For Treatment

Misty Richards et al.

AMERICAN JOURNAL OF PSYCHIATRY (2019)

Article Cardiac & Cardiovascular Systems

TPO-Ab plays a role in arterial remodeling in patients with intracranial stenosis

Xuting Zhang et al.

ATHEROSCLEROSIS (2019)

Article Multidisciplinary Sciences

Dysregulation of RNF213 promotes cerebral hypoperfusion

Takaaki Morimoto et al.

SCIENTIFIC REPORTS (2018)

Article Biochemistry & Molecular Biology

Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians

Stephanie Guey et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2017)

Review Public, Environmental & Occupational Health

Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review

Xin Liao et al.

ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE (2017)

Review Public, Environmental & Occupational Health

A new horizon of moyamoya disease and associated health risks explored through RNF213

Akio Koizumi et al.

ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE (2016)

Review Clinical Neurology

Research Progresses in Understanding the Pathophysiology of Moyamoya Disease

Anna Bersano et al.

CEREBROVASCULAR DISEASES (2016)

Article Biochemistry & Molecular Biology

Vasculogenic and Angiogenic Pathways in Moyamoya Disease

Gloria Bedini et al.

CURRENT MEDICINAL CHEMISTRY (2016)

Article Clinical Neurology

Determinants of Basal Collaterals in Moyamoya Disease: Clinical and Genetic Factors

Jong-Won Chung et al.

EUROPEAN NEUROLOGY (2016)

Article Multidisciplinary Sciences

A Polymorphism in RNF213 Is a Susceptibility Gene for Intracranial Atherosclerosis

Oh Young Bang et al.

PLOS ONE (2016)

Review Clinical Neurology

Moyamoya Disease: Epidemiology, Clinical Features, and Diagnosis

Jong S. Kim

JOURNAL OF STROKE (2016)

Article Multidisciplinary Sciences

RNF213 Rare Variants in Slovakian and Czech Moyamoya Disease Patients

Hatasu Kobayashi et al.

PLOS ONE (2016)

Article Clinical Neurology

Distinct clinical and radiographic characteristics of moyamoya disease amongst European Caucasians

G. Acker et al.

EUROPEAN JOURNAL OF NEUROLOGY (2015)

Article Radiology, Nuclear Medicine & Medical Imaging

Noninvasive method for mapping CVR in moyamoya disease using ASL-MRI

Tomoyuki Noguchi et al.

EUROPEAN JOURNAL OF RADIOLOGY (2015)

Review Clinical Neurology

Asymptomatic Moyamoya Disease: Literature Review and Ongoing AMORE Study

Satoshi Kuroda

NEUROLOGIA MEDICO-CHIRURGICA (2015)

Article Clinical Neurology

Vascular remodeling of the circle of Willis in moyamoya disease

Takeshi Mikami et al.

NEUROLOGICAL RESEARCH (2015)

Article Biochemistry & Molecular Biology

Ablation of Rnf213 retards progression of diabetes in the Akita mouse

Hatasu Kobayashi et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)

Article Genetics & Heredity

Immune response profiling identifies autoantibodies specific to Moyamoya patients

Tara K. Sigdel et al.

ORPHANET JOURNAL OF RARE DISEASES (2013)

Article Public, Environmental & Occupational Health

P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure

Akio Koizumi et al.

ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE (2013)

Review Immunology

The role of dendritic cells in autoimmunity

Dipyaman Ganguly et al.

NATURE REVIEWS IMMUNOLOGY (2013)

Article Biochemistry & Molecular Biology

Phenotype Switch of Vascular Smooth Muscle Cells After siRNA Silencing of Filamin

Guangming Zhu et al.

CELL BIOCHEMISTRY AND BIOPHYSICS (2011)

Article Genetics & Heredity

A genome-wide association study identifies RNF213 as the first Moyamoya disease gene

Fumiaki Kamada et al.

JOURNAL OF HUMAN GENETICS (2011)

Review Medicine, General & Internal

MEDICAL PROGRESS Moyamoya Disease and Moyamoya Syndrome

R. Michael Scott et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Radiology, Nuclear Medicine & Medical Imaging

Microbleeds in Moyamoya disease: susceptibility-weighted imaging versus T2*-weighted imaging at 3 tesla

Nobuyuki Mori et al.

INVESTIGATIVE RADIOLOGY (2008)

Review Clinical Neurology

Moyamoya disease: current concepts and future perspectives

Satoshi Kuroda et al.

LANCET NEUROLOGY (2008)

Article Clinical Neurology

Moyamoya disease in Washington state and California

K Uchino et al.

NEUROLOGY (2005)